Speaker illustration

Doctor Santiago Jimenez-Marrero

Bellvitge University Hospital, Hospitalet De Llobregat (Spain)

Member of:

European Society of Cardiology
Heart Failure Association

Management of renin-angiotensin-aldosterone system inhibitors in patients with chronic cardiovascular conditions and its association with clinical outcomes

Event: ESC Congress 2022

Topic: Epidemiology, Prognosis, Outcome

Session: Chronic heart failure - Epidemiology, prognosis, outcome 1

Thumbnail

Implications of hyperkalemia in the management of renin-angiotensin-aldosterone system inhibitors in patients with chronic cardiovascular conditions and its association with clinical outcomes

Event: Heart Failure 2022

Topic: Epidemiology, Prognosis, Outcome

Session: Heart Failure ePosters - focus on Chronic Heart Failure 9

Thumbnail

36,269 patients with chronic cardiovascular, metabolic and renal conditions: impact on clinical outcomes, medical resource use and health-related costs of deranged serum potassium levels

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Epidemiology, Prognosis, Outcome

Session: Changing Epidemiology of Heart Failure

Thumbnail

A population-based analysis in 375,233 cases of heart failure stages A, B and C. Real world epidemiology of prevalence and temporal trends in South-European populations

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Epidemiology, Prognosis, Outcome

Session: Chronic Heart Failure ePosters

Thumbnail

Epidemiology of potassium derangements among chronic cardiovascular, metabolic and renal conditions: a population-based analysis data from more than 375,000 individuals

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Epidemiology, Prognosis, Outcome

Session: Chronic Heart Failure ePosters

Thumbnail

Impact on clinical events and healthcare costs of adding telemedicine to multidisciplinary care of patients with heart failure and mid-range or preserved LVEF: a randomised controlled trial

Event: ESC CONGRESS 2017

Topic: AHF - Non pharmacological treatment

Session: Acute Heart Failure (AHF)

Thumbnail

This platform is supported by

logo Novo Nordisk